| Literature DB >> 31630194 |
Eric Rogier1, Karen E S Hamre1, Vena Joseph2, Mateusz M Plucinski1, Jacquelin Presume3, Ithamare Romilus3, Gina Mondelus3, Tamara Elisme3, Lotus van den Hoogen4, Jean Frantz Lemoine5, Chris Drakeley4, Ruth A Ashton2, Michelle A Chang1, Alexandre Existe3, Jacques Boncy3, Gillian Stresman4, Thomas Druetz2,6, Thomas P Eisele2.
Abstract
Accurate malaria diagnosis is foundational for control and elimination, and Haiti relies on histidine-rich protein 2 (HRP2)-based rapid diagnostic tests (RDTs) identifying Plasmodium falciparum in clinical and community settings. In 2017, 1 household and 2 easy-access group surveys tested all participants (N = 32 506) by conventional and high-sensitivity RDTs. A subset of blood samples (n = 1154) was laboratory tested for HRP2 by bead-based immunoassay and for P. falciparum 18S rDNA by photo-induced electron transfer polymerase chain reaction. Both RDT types detected low concentrations of HRP2 with sensitivity estimates between 2.6 ng/mL and 14.6 ng/mL. Compared to the predicate HRP2 laboratory assay, RDT sensitivity ranged from 86.3% to 96.0% between tests and settings, and specificity from 90.0% to 99.6%. In the household survey, the high-sensitivity RDT provided a significantly higher number of positive tests, but this represented a very small proportion (<0.2%) of all participants. These data show that a high-sensitivity RDT may have limited utility in a malaria elimination setting like Haiti. Published by Oxford University Press for the Infectious Diseases Society of America 2019.Entities:
Keywords: zzm321990 Plasmodium falciparumzzm321990 ; HRP2; Haiti; malaria elimination; rapid diagnostic test
Mesh:
Substances:
Year: 2020 PMID: 31630194 PMCID: PMC8211410 DOI: 10.1093/infdis/jiz525
Source DB: PubMed Journal: J Infect Dis ISSN: 0022-1899 Impact factor: 5.226